Navigation Links
K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
Date:11/17/2010

p>(24)   delays in returning, or failure to return, certain or many of the Registrant's approved products to the market, including loss of market share as a result of the suspension of shipments, and related costs;

(25)   the ability to sell or license certain assets, and the terms of such transactions;

(26)   the possibility that default on one type or class of the Registrant's indebtedness could result in cross default under, and the acceleration of, its other indebtedness;

(27)   the risks that present or future changes in the Board of Directors or management may lead to an acceleration of the Registrant's bonds or to adverse actions by government agencies or our auditors;

(28)   the risk that even though the price and 30-day average price of the Registrant's Class A common stock and Class B common stock satisfies the quantitative listing standards of the New York Stock Exchange, including with respect to minimum share price and public float, the Registrant can provide no assurance that they will remain at such levels thereafter;

(29)   the risk that BDO will be unable to complete the audit of the Company's financial statements to be included in its annual report for its fiscal year ended March 31, 2010 in order for the Company to meet the extension period granted by the New York Stock Exchange to comply with their listing standards and the subsequent risk that the inability to complete the Form-10-Q's for fiscal year 2011 on a timely basis could impact the timely filing of the fiscal year 2011 Form 10-K.

(30)   the risks detailed from time-to-time in the Registrant's filings with the SEC.

This discussion is not exhaustive, but is designed to highlight important factors that may impact the Registrant's forward-looking statements.  Because the factors referred to above, as well as the statements included elsewhere in this report and in the exhibits hereto, could cause actual r
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Thoratec Corporation (NASDAQ: ... mechanical circulatory support therapies to save, support and restore ... the 2014 Morgan Stanley Global Healthcare Conference on Wednesday, ... President and Chief Executive Officer, will provide an update ... Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Benefiting ... for medical expenses, the Chinese orthopedic instrument market demand ... CAGR of 19.2% during 2009-2013. Trauma products, spine products ... instruments in China , of which ...
(Date:8/29/2014)... -- Research and Markets  has announced the addition of ... report to their offering. The Central Nervous ... largest segments of pharmaceuticals industry. The numbers of CNS disorders ... were unable to meet the market requirements. There has been ... especially over the past two decades. The market for CNS ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2
... Nov. 18 Disabled American Veterans (DAV) announces the launch of ... 75% and when the card is used, 50 cents will be ... , The free prescription drug cards may be used by ... a time when non-profit organizations are seeing a decline in charitable ...
... , CLEVELAND, Nov. 18 ... consumers over the counter throughout Greater Cleveland, one of two cities ... a nationwide product launch. The MyClyns spray has been used and ... years and is now available on store shelves for the very ...
Cached Medicine Technology:FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for America's Disabled Veterans 2MyClyns(R) Now Available to Greater Clevelanders 2
(Date:9/1/2014)... be able to convince your brain that healthy foods taste ... included eight overweight and obese people who were enrolled in ... react to different foods. These participants were compared to a ... in the program. Both groups had MRI brain scans ... later. The scans revealed that the people in the weight-loss ...
(Date:9/1/2014)... 2014 An operating theatre or operating ... performing surgical operations. An operating room comprises a myriad ... operating room lights, imaging displays as well as integration ... Transparency Market Research, a U.S.-based market research firm, the ... 4.5 billion by 2019. , According to this ...
(Date:9/1/2014)... Dennis Thompson HealthDay Reporter ... Ebola drug previously given to two American aid workers successfully ... in laboratory tests, researchers report. The drug, ZMapp, prompted ... they didn,t get the medication until five days after infection. ... who were days or even hours away from death, said ...
(Date:9/1/2014)... The National Association of Hispanic Nurses ... Bazarko, DNP, MPH, RN, and Adriana Perez, PhD, Rn, ... of Nursing. They will be inducted with Immediate Past ... induction we reported last May. , Our three members ... 2014 American Academy of Nursing Policy Conference in Washington, ...
(Date:9/1/2014)... involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) are ... where issues related to claims involving the pain reliever ... Bernstein Liebhard LLP reports. , According to a ... the meeting is scheduled to take place on September ... of several Tylenol conferences that have taken place this ...
Breaking Medicine News(10 mins):Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4
... St. Luke,s Closure to Have Disproportionate Impact On Latinos, Other ... ... Sutter Health,s planned,closure of St. Luke,s Hospital in San Francisco ... as evidenced by new state,data released today by the California ...
... more than doubled the odds, study found , , THURSDAY, Oct. ... conditions more than double their risk of needing subsequent surgery ... was true regardless of what type of surgical technique was ... article is published in the Oct. 27 issue of ...
... lowers blood pressure might help prevent Alzheimer disease ... the most common form of dementia, is characterized by ... beta-amyloid protein. Recent evidence indicates that some drugs used ... the risk of developing AD. In a new study, ...
... PHILADELPHIA A new Center for Excellence in Ethical, ... at the University of Pennsylvania School of Medicine, a ... Sciences, the Wharton School and the Annenberg School for ... of Genetic Healthcare Technology (Penn CIGHT) will receive over ...
... of Michigan is the lead research institution in a ... the health consequences on victims in disasters. , ... Health Research, includes researchers from U-M, Dartmouth Medical School, ... University of Oklahoma. The center is funded by the ...
... prevents formation of beta-amyloid clumps in mice, study says ... pressure drug valsartan shows the ability to reduce Alzheimer,s ... value of valsartan, marketed as Diovan, emerged from a ... drugs, said study author Dr. Giulio Maria Pasinetti, a ...
Cached Medicine News:Health News:CNA Presents New Data on Sutter's Medical Redlining 2Health News:CNA Presents New Data on Sutter's Medical Redlining 3Health News:Hysterectomy May Boost Incontinence Risk 2Health News:Hysterectomy May Boost Incontinence Risk 3Health News:JCI table of contents: Oct. 25, 2007 2Health News:JCI table of contents: Oct. 25, 2007 3Health News:JCI table of contents: Oct. 25, 2007 4Health News:JCI table of contents: Oct. 25, 2007 5Health News:JCI table of contents: Oct. 25, 2007 6Health News:JCI table of contents: Oct. 25, 2007 7Health News:JCI table of contents: Oct. 25, 2007 8Health News:JCI table of contents: Oct. 25, 2007 9Health News:Penn wins $5M to start center for ethical, legal and social implications research 2Health News:Penn wins $5M to start center for ethical, legal and social implications research 3Health News:U-M to lead disaster aftermath research center 2Health News:Blood Pressure Drug Might Work Against Alzheimer's 2
... concave seats and large backrests with ... seats, backrests, armrests, and casters and ... for top performance in a variety ... clean room, static control, health care ...
... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With tubular base • unit ...
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With tubular base • unit ...
Medicine Products: